AWARDDELIVERY ORDEROther than small business
Delivery order 75F40123F19005ACUMEN LLC
Overview
Award facts
- Net obligations
- $22.16M
- $22,161,469of $22.16M potential value
- Outlays (paid to date)
- $22.09M
- $22.09M paid of $22.16M obligated$22,087,425
- Period of performance
- Sep 27, 2023 to Sep 29, 2025
- Ended
- Modifications
- 4
- Latest action Jul 22, 2025
- Contract type
- Delivery order
- PIID 75F40123F19005
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE: INFRASTRUCTURE AND DATA FOR SURVEILLANCE OF BIOLOGICS (TASK ORDER 0005)
Dates and value
- Award date
- Signed on Sep 27, 2023
- Potential end of performance
- Sep 28, 2025
- Current value
- $22,161,469Base and exercised options
- Potential value (if all options are exercised)
- $22,161,469
- Parent contract vehicle
- 75F40118D10020 (IDC, multiple award) — 5 orders recorded under it
Obligations by fiscal year of action
- FY2024: $10,721,221
- FY2023: $11,440,248
Total across 2 fiscal years: $22,161,469
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 22, 2025. View on USAspending · Recipient on SAM.gov
Recipient
NameACUMEN LLC
LocationBURLINGAME, CA
UEIXVMTJF1497P1
CAGE code3MQD9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typePartnership
Parent companyACUMEN LLC
Business types and certifications
For-profit organizationLimited liability companyPartnership or LLP
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Cures activities; Direct program activity; Biologics; Coronavirus emergency funding supplemental; Fda user fees (non general fund)Program activities075-0600, 075-0945, 075-5629Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Burlingame, San Mateo County, California 94010-1980
- Congressional district (place of performance)
- CA-15As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- B537SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Time and materialsY
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- RFTOP-CBER-2023-116135(as reported)
- Solicitation date
- Jul 7, 2023
Contract details
- Subcontracting plan
- Individual subcontract planF
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Transaction history
Modification history
- Base award
- Sep 27, 2023Base obligation at award: $11,440,248
- Latest action
- Jul 22, 2025 — Other administrative actionModification P00004; administrative: no change in scope or value
- Latest substantive action
- Sep 24, 2024 — Option exercisedModification P00002; obligation change +$10,946,221
- Actions by type
- Base award1
- Other administrative action2
- Supplemental agreement (within scope)1
- Option exercised1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Multiple awardM
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2023/2023-0600-000
- 075-2024/2024-0600-000
- 075-X-0600-000
- 075-X-0945-000
- 075-X-5629-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- COVID-19 supplemental obligations
- $2,525,000
- COVID-19 supplemental outlays
- $2,525,000